You have 9 free searches left this month | for more free features.

Mastocytosis, Systemic

Showing 26 - 50 of 8,222

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Adaptation of Questionnaire "Regarding Patient's Quality of Life

Completed
  • Cutaneous Mastocytosis
  • Indolent Systemic Mastocytosis
  • A structured interview with every patient
  • Toulouse, France
    University Hospital Toulouse
Jul 15, 2019

Mast Cell Activation Disease, Mast Cell Activation Syndrome, Mast Cell Disease Trial in Poitiers (Ophthalmological examination)

Recruiting
  • Mast Cell Activation Disease
  • +3 more
  • Ophthalmological examination
  • Poitiers, Nouvelle Aquitaine, France
    Masson Regnault
Apr 12, 2022

Systemic Mastocytosis Trial in France, Martinique (Mastocytosis diagnosis)

Completed
  • Systemic Mastocytosis
  • Mastocytosis diagnosis
  • Bordeaux, France
  • +7 more
Jul 11, 2019

Cause and Natural Course of Pediatric-Onset Mastocytosis

Completed
  • Mastocytosis
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Dec 14, 2019

    Are Mast Cells Involved in Autoinflammatory Diseases

    Not yet recruiting
    • Autoinflammatory Disease
    • +5 more
      • Paris, France
        Service de Médecine Interne
      Mar 22, 2022

      Indolent Systemic Mastocytosis Trial in Berlin (AK002)

      Completed
      • Indolent Systemic Mastocytosis
      • Berlin, Germany
        Charité - Universitätsmedizin Berlin
      Mar 12, 2019

      Aggressive Systemic Mastocytosis, Mast Cell Leukemia, Systemic Mastocytosis Trial in Stanford, Houston (Brentuximab vedotin)

      Completed
      • Aggressive Systemic Mastocytosis
      • +2 more
      • Brentuximab vedotin
      • Stanford, California
      • +1 more
      Jan 9, 2019

      Mastocytosis Trial in Cambridge

      Completed
      • Mastocytosis
        • Cambridge, Massachusetts
          Registry participation is worldwide and not limited to this faci
        Feb 3, 2021

        Aggressive Systemic Mastocytosis, Mast Cell Leukemia, Systemic Mastocytosis Trial in Stanford (Ibrutinib)

        Terminated
        • Aggressive Systemic Mastocytosis
        • +2 more
        • Stanford, California
          Stanford University Hospitals and Clinics
        Aug 24, 2018

        Cutaneous Mastocytosis Trial in Toulouse (Pigment laser)

        Recruiting
        • Cutaneous Mastocytosis
        • Pigment laser
        • Toulouse, France
          Larrey Hospital - Toulouse University Hospital
        Sep 23, 2020

        Systemic Mastocytosis, Aggressive (ASM), Leukemia, Mast Cell, Hematological Non-mast Cell Lineage Disease (AHNMD) Trial in

        Completed
        • Systemic Mastocytosis, Aggressive (ASM)
        • +2 more
        • Stanford, California
        • +2 more
        Sep 19, 2018

        Core Binding Factor Acute Myeloid Leukemia, KIT Mutation-Related Tumors Trial in Suzhou (Avapritinib)

        Recruiting
        • Core Binding Factor Acute Myeloid Leukemia
        • KIT Mutation-Related Tumors
        • Suzhou, Jiangsu, China
          First Affiliated Hospital of Soochow University
        Apr 7, 2023

        Mastocytosis Trial (masitinib (AB1010))

        Completed
        • Mastocytosis
        • masitinib (AB1010)
        • (no location specified)
        Dec 8, 2018

        Mast Cell Activation Syndrome Trial in Weldon Spring, Toulouse (Masitinib 4.5 mg/kg/day, Placebo, Best supportive care)

        Recruiting
        • Mast Cell Activation Syndrome
        • Masitinib 4.5 mg/kg/day
        • +3 more
        • Weldon Spring, Missouri
        • +1 more
        Jul 18, 2022

        Serum Basal Tryptase Levels in Healthy Children

        Completed
        • Basal Tryptasemia
        • Tryptase dosage
        • Paris, France
          Hôpital Necker-Enfants Malades
        Dec 8, 2022

        Patient With Facial Erythema Trial in Assiut (Tranexamic Acid 500 MG)

        Completed
        • Patient With Facial Erythema
        • Tranexamic Acid 500 MG
        • Assiut, Egypt
          Azhar University
        Jun 9, 2023

        Relevance of Self-assessment of Skills for Self-administration

        Not yet recruiting
        • Severe Anaphylactic Reaction, Self-administration, Adrenaline, Self-assessment
          • (no location specified)
          May 30, 2022

          Study of Factors Regulating Mast Cell Proliferation

          Recruiting
          • Mastocytosis
          • +3 more
            • Bethesda, Maryland
              National Institutes of Health Clinical Center
            Feb 2, 2023

            Inherited Bone Marrow Failure Syndrome, Familial Platelet Disorder With Predisposition to Myeloid Malignancies Trial run by the

            Not yet recruiting
            • Inherited Bone Marrow Failure Syndrome
            • Familial Platelet Disorder With Predisposition to Myeloid Malignancies
            • Bethesda, Maryland
              National Institutes of Health Clinical Center
            Oct 20, 2023

            Leukemia Trial in Worldwide (Midostaurin (PKC412))

            Completed
            • Leukemia
            • Midostaurin (PKC412)
            • Los Angeles, California
            • +28 more
            Oct 16, 2018

            Cutaneous Mastocytoses Trial in Rochester (Topical preparation of sodium cromolyn 5%, diphenhydramine 1% and trolamine

            Recruiting
            • Cutaneous Mastocytoses
            • Topical preparation of sodium cromolyn 5%, diphenhydramine 1% and trolamine salicylate 10% in emollient cream base.
            • Rochester, Minnesota
              Mayo Clinic in Rochester
            Mar 11, 2022

            Schizophrenia, Schizo Affective Disorder Trial in Pittsburgh (Cromoglycate, Placebo)

            Recruiting
            • Schizophrenia
            • Schizo Affective Disorder
            • Pittsburgh, Pennsylvania
              University of Pittsburgh
            Jan 4, 2023

            Chronic Myelomonocytic Leukemia, Chronic Myeloid Leukemia, Polycythemia Vera Trial in Houston (Imatinib Mesylate (Gleevec))

            Completed
            • Chronic Myelomonocytic Leukemia
            • +4 more
            • Imatinib Mesylate (Gleevec)
            • Houston, Texas
              UT MD Anderson Cancer Center
            Dec 7, 2021

            Non Small Cell Lung Cancer Trial in Sweden (Standard systemic therapy + radiotherapy, Standard systemic therapy)

            Not yet recruiting
            • Non Small Cell Lung Cancer
            • Standard systemic therapy + radiotherapy
            • Standard systemic therapy
            • Gothenburg, Sweden
            • +5 more
            Nov 17, 2023